Sjællands Universitetshospital, Køge tidligere Køge Sygehus er et sygehus i Ølby ved Køge. Før kommunalreformen, hvor det hørte under Roskilde Amt, bar det navnet Roskilde Amts Sygehus Køge, forkortet RASK.

During the past decade, Køge Sygehus conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Køge Sygehus" #1 sponsor was "Zealand University Hospital" with 16 trials, followed by "Celgene" with 3 trials sponsored, "Naestved Hospital" with 3 trials sponsored, "Advanz Pharma" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Køge Sygehus" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Zealand University Hospital" with 2 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bispebjerg Hospital" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Køge Sygehus" are "Ventral Hernia" (5 trials), "Arthritis, Psoriatic" (2 trials), "Atrial Fibrillation" (2 trials), "Crohn Disease" (2 trials) and "Myocardial Injury" (2 trials). Many other conditions were trialed in "Køge Sygehus" in a lesser frequency.

Most popular intervention types in "Køge Sygehus" are "Drug" (16 trials), "Procedure" (5 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Dexamethasone" (3 trials), "GED-0301" (3 trials), "Guselkumab" (2 trials) and "Isotonic saline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Køge Sygehus" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Køge Sygehus". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Køge Sygehus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Køge Sygehus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".